Submitted by Anonymous (not verified) on 1 April 2026 - 16:04
Human medicines European public assessment report (EPAR): RoActemra, tocilizumab, Date of authorisation: 16/01/2009, Revision: 49, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): RoActemra, tocilizumab, Date of authorisation: 16/01/2009, Revision: 49, Status: Authorised